Articles

The top therapeutic advancements in myopia, diabetes, dry eye and more

Trending topics and milestone stories from our year in ophthalmology

The number of patients with retinal vascular diseases is expected to increase over time due to the aging population and lifestyle changes

Our top 10 print stories highlight the core content concepts we explored this year

The Danish Medicines Agency requested the EMA's Pharmacovigilance Risk Assessment Committee review reports on the vision-threatening condition

Low-level light therapy for dry eye disease and chalazion

The timeline demonstrates international innovation and collaboration

Sophisticated programmes require an evolving mindset

Espansione Group's Light Modulation Low-level Light Therapy (LLLT) is used in ophthalmology and dermatology

Ocular clues to a neurological conditions help clinicians understand neuromyelitis optica spectrum disorder (NMOSD)

The European Commission will assess the marketing authorisation for Eydenzelt (reference product Eylea)

A confirmed diagnosis of familial exudative vitreoretinopathy aids in several aspects of patient management

The PFS is approved for treatment of neovascular age-related macular degeneration, diabetic macular oedema and macular oedema following retinal vein occlusion

Phenocell and Amarna Therapeutics were awarded the grant by Eureka’s Eurostars initiative, co-funded by the European Union

A retrospective study assessed elevated neutrophil-to-lymphocyte ratios and systemic immune-inflammation index levels in patients with different subtypes of DMO

The research findings supported the hypothesis that a mild reduction in retinal contrast can slow myopia progression in young children

Clinicians must consider redefining the metrics and intention behind functional outcomes, according to experts from the European Association for the Study of Diabetic Eye Complications

Presentation closely resembled mitogen-activated extracellular signal-regulated kinase inhibitor–associated retinopathy

The annual meeting brought fourth announcements and insights from companies in the retina care space

Lenticule Extraction for treating patients with hyperopia is now available with SMILE® pro, performed on the VISUMAX® 800 from ZEISS. This additional option provides a valuable corneal-based alternative for younger patients without cataract. In this Case of the Month, you will discover the advantages of this procedure and review the outcomes of a 30-year-old patient who chose to undergo Lenticule Extraction with ZEISS SMILE pro after experiencing discomfort with contact lenses for many years.

EAB members from Ophthalmology Times Europe, Ophthalmology Times and Modern Retina are presenting in Florence

Breakthrough technologies are raising the ceiling for functional visual outcomes

What to expect from 4 days in the Fortezza de Basso

The differential recruitment of the dorsal and ventral visual streams

Gauging patient perceptions in an ethnically diverse UK cohort

The Belgian B Corp company, founded in 2016, is partially owned by Rayner and distributed in over 20 European countries

The authors analysed severity and frequency of ocular pain among patients with DED living in altitudes above 2,500 meters during the COVID-19 pandemic

A higher body mass index was protective against glaucoma progression, while patients who were underweight had significantly faster rates of structural loss

The annual meeting held in Chicago, Illinois, featured new data and best practices for patient-centred care

OCU410ST is indicated for the treatment of ABCA4-associated retinopathies including Stargardt disease, retinitis pigmentosa and cone-rod dystrophy 3 (CORD3)